121
1. Akalin H, Helvaci S, Gedikoğlu S. Re-emergence of tularemia in Turkey. Int J Infect Dis. 2009;13(5):547-551. doi:10.1016/j.ijid.2008.09.020
2. Barut S, Cetin I. A tularemia outbreak in an extended family in Tokat Province, Turkey: observing the attack rate of tularemia. Int J Infect Dis. 2009;13(6):745-748. doi:10.1016/j.ijid.2008.12.002
3. Bayram Y, Özkaçmaz A, Parlak M, et al. Van ili ve çevresinde risk altındaki insan ve hayvan gruplarında tularemi seroprevalansı [Seroprevalence of tularemia in risk groups of humans and animals in Van, eastern Turkey]. Mikrobiyol Bul. 2015;49(4):532-541. doi:10.5578/mb.9966
4. CDC. Bioterrorism Agents/diseases-Categories A, B, and C. https://.emergency.cdc.gov/agents/agentlist-category.asp (Erişim tarihi:18.08.2025)
5. Centers for Disease Control and Prevention (CDC). (2023). Tularemia data and statistics. https://www.cdc.gov/tularemia/data-research (Erişim tarihi:18.08.2025).
6. Dennis DT, Inglesby TV, Henderson DA, et al. Working Group on Civilian Biodefense. Tularemia as a biological weapon: medical and public health management. JAMA 2001;285:2763-73. doi:10.1001/jama.285.21.2763
7. Ellis J, Oyston PC, Green M, et al. Tularemia. Clin Microbiol Rev. 2002;15(4):631-646. doi:10.1128/CMR.15.4.631-646.2002
8. Gürcan S. Epidemiology of tularemia. Balkan Med J. 2014;31(1):3-10. doi:10.5152/balkanmedj.2014.13117
9. Keim P, Johansson A, Wagner DM. Molecular epidemiology, evolution, and ecology of Francisella. Ann N Y Acad Sci. 2007;1105:30-66. doi:10.1196/annals.1409.011
10. Kılıç, S. A general overview of Francisella tularensis and the epidemiology of tularemia in Turkey. FLORA 2010, 15(2); 37–58.
11. Kugeler KJ, Mead PS, Janusz AM, et al. Molecular Epidemiology of Francisella tularensis in the United States. Clin Infect Dis. 2009;48(7):863-870. doi:10.1086/597261
12. Maurin M, Gyuranecz M. Tularaemia: clinical aspects in Europe. Lancet Infect Dis. 2016;16(1):113-124. doi:10.1016/S1473-3099(15)00355-2
13. McLendon MK, Apicella MA, Allen LA. Francisella tularensis: taxonomy, genetics, and Immunopathogenesis of a potential agent of biowarfare. Annu Rev Microbiol. 2006;60:167-185. doi:10.1146/annurev.micro.60.080805.142126
14. Nelson C, (Eds: Calderwood SB, Bloom A) Clinical manifestations,diagnosis,treatment and prevention of tularemia. https://www.uptodate.com/contents/tularemia-clinical-manifestations-diagnosis-treatment-and-prevention (Erişim tarihi:18.08.2025)
15. Penn RL (Eds: Calderwood SB, Bloom A) Tularemia microbiology, epidemiology and pathogenesis. https://www.uptodate.com/contents/tularemia-microbiology-epidemiology-and-pathogenesis (Erişim tarihi:18.08.2025).
16. Sjöstedt A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci. 2007;1105:1-29. doi:10.1196/annals.1409.009
17. Tärnvik A, Berglund L. Tularaemia. Eur Respir J 2003;21(2):361-373. doi:10.1183/09031936.03.00088903
18. Türkiye’de Tularemi Mevcut Durum Raporu, Current Situation Report of Tularemia in Türkiye, T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, Yayın No: 1291, Ankara, 2024. (Erişim adresi: https://hsgm.saglik.gov.tr/depo/birimler/zoonotik-ve-vektorel-hastaliklar-db/Dokumanlar/Raporlar/Tr_Tularemi_Mevcut_Durum.pdf)
19. WHO, Laboratory biosafety manual, 4th ed., 2020. https//www.who.int/publications/i/item/9789240011311 (Erişim tarihi:18.08.2025)
20. World Health Organization. (2007). Tularemia: Fact sheet. Retrieved from https://www.who.int/ (Erişim tarihi:18.08.2025).